Nationwide Response to Carboplatin and Cisplatin Shortages in Lung Cancer
This observational study examines the clinical response to cisplatin and carboplatin shortages among patients with lung cancer.
Authors
- Navneet Singh (ORCID: https://orcid.org/0000-0002-8389-0701)
- John Kent Lin (ORCID: https://orcid.org/0000-0003-2490-4453)
- Changchuan Jiang (ORCID: https://orcid.org/0000-0002-7392-4154)
- Ya‐Chen Tina Shih (ORCID: https://orcid.org/0000-0001-7290-3864)
- Jenny Xiang (ORCID: https://orcid.org/0000-0003-4390-7641)
- Ying Xu (ORCID: https://orcid.org/0000-0002-9454-4337)
- Mariana Chavez-MacGregor
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Colorado Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1001/jamaoncol.2025.3768
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00